microcap

The Lottery Ticket Stocks Q2 2019 portfolio was down 6.72% for the quarter, tracking the Russell 2000 Index lower. However, the portfolio of top hedge funds' most speculative holdings, rebalanced quarterly based on 13F filings, was up 35.65% year-to date as of August 15.

Replicating Baker Brothers holdings, using 13F filings submitted quarterly by the life sciences hedge fund, has been an awesome strategy over the years. But by focusing on the smaller stocks owned by the fund, returns were even better. Baker Bros Advisors LP, with $17.33...

Lottery ticket stocks are equities perceived by investors to provide a small chance of a huge payoff. Like playing the lottery, many investors find these stocks -- usually low-priced, thinly traded with little or no earnings -- very alluring. However, studies show that -- like the...

In a 13D filed Friday after market hours, Ault Global disclosed a 9.96% position in NTN Buzztime (NTN), a provider of interactive entertainment to sports bars and other venues across North America. Ault called NTN "undervalued and represented an attractive investment opportunity." On Jan....

On April 30, Phillip Goldstein disclosed a 9.9976% position in Herzfeld Caribbean Basin Ltd. (CUBA). In a 13D filing, Goldstein said that if the founder and manager of the CUBA closed-end fund was to "dissolve" it, shareholders would gain "about 25%." Goldstein is...

Whether they’re called penny stocks, micro-caps, OTC stocks or “lottery tickets,” low-priced, illiquid stocks of small companies have a bad reputation with many investors. Unquestionably micro-cap stocks can be illiquid, risky and highly speculative. Nonetheless, Hedge Funds can and do hold lots of micro-caps.

Obscure stocks -- publicly traded, unknown, hidden companies with little or even no analyst coverage -- may not seem like good investments. Seriously, who wants to invest in a stock no one has ever heard of? Some of the top hedge fund managers in the world, that's...

Twenty-two minutes after regular market hours closed on July 2, an Orbimed Advisors Form 4 relating to Corvus Pharmaceuticals Inc (CRVS) was posted on the SEC's website. The hedge fund, a 10%+ holder and insider in CRVS, disclosed that between June 27 and July 1 it...

On February 28 , Martha Stewart's Sequential Brands (SQBG) announced that the lifestyle celebrity has teamed up with Canopy Brands (CGC) to develop and promote a line of hemp-based CBD products. SQBG stock spiked higher on the news, nearly doubling at one point before settling at $2.00...

Billionaire Mori Arkin filed a 13D on Aclaris Therapeutics (ACRS), a development stage microcap biotech company with a promising treatment for common warts. Arkin bought the shares through his personal partnership, "The 1999 Company." In the activist filing he disclosed the following trades: Purchase/SaleSharesPriceDate Running ...